Cargando…

Perioperative adrenergic response and the use of beta-blockers

Detalles Bibliográficos
Autor principal:	Kim, Tae-Yop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Anesthesiologists 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188759/ https://www.ncbi.nlm.nih.gov/pubmed/25302091 http://dx.doi.org/10.4097/kjae.2014.67.3.161

Ejemplares similares

Small but serious risk of perioperative steroid use
por: Kim, Tae-Yop
Publicado: (2017)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Can beta-adrenergic blockers be used in the treatment of COVID-19?
por: Vasanthakumar, Natesan
Publicado: (2020)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma
por: Rossi, Maïlys, et al.
Publicado: (2022)

Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)

Adverse effects of beta adrenergic blockers during spinal anesthesia with 0.5% bupivacaine
por: Vukelić, J, et al.
Publicado: (2010)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

Clinical Impact of Beta-blockers in the Revascularization Era
por: Kang, Soo-Jin
Publicado: (2020)

Beta-Blockers: A Tale of Triumphs, Trials, and Tribulations
por: Singh, Jagjit
Publicado: (2020)

Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis
por: Vallurupalli, Srikanth, et al.
Publicado: (2010)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients
por: Berends, Annika M. A., et al.
Publicado: (2022)

Contrast nephropathy: Risk factors and the role of beta blockers
por: Bowden, Rodney G.
Publicado: (2015)

At the Crossroads of Cardiac Beta-Adrenergic Receptor Signaling and Myocardial Glucose Metabolism
por: Kereliuk, Stephanie M., et al.
Publicado: (2023)

Prevention of perioperative atrial fibrillation with beta blockers in elderly patient during abdominal surgery
por: Pagano, Gennaro, et al.
Publicado: (2013)

Recovery from sedation during regional anesthesia
por: Kim, Tae-Yop
Publicado: (2013)

Beta-blocker therapy in refractory ascites: A steady march towards the truth
por: Bartell, Nicholas, et al.
Publicado: (2022)

Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007)

HEDIS, Beta-Blockers, and What More Can Be Done to Improve Secondary Prevention in ACS
por: Curtiss, Frederic R.
Publicado: (2008)

Mechanisims of asthma and allergic disease – 1069. Down regulation of IL-13 secretion in mononuclear cells by a beta-adrenergic blocker
por: Hajighasemi, Fatemeh
Publicado: (2013)

Intravenous ephedrine abolished suspected bronchoconstriction during general anesthesia in a patient undergoing beta-adrenergic blocker therapy for hypertension
por: Oshika, Hiroyuki, et al.
Publicado: (2019)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Does preoperative beta-blocker offer myocardial protection during coronary artery bypass grafting?
por: Rocha, Bruno da Costa
Publicado: (2013)

ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker
por: Lainscak, Mitja, et al.
Publicado: (2016)

Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could Their Use Be Vindicated as an Acceptable Option in the Future Treatment Guideline?
por: Cho, Jae Yeong
Publicado: (2019)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection
por: Kim, Tae Ho
Publicado: (2023)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
por: Bartell, Nicholas, et al.
Publicado: (2018)

Response to: A myth of ophthalmic beta-blockers therapy
por: Wolfs, Roger C. W.
Publicado: (2009)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

Beta-blocker under-use in COPD patients
por: Lim, Kuan Pin, et al.
Publicado: (2017)

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8e8jufrtrn3nrnb5tolhkp8r1o